A cross-country index of intellectual property rights inpharmaceutical inventions
-
Maximizing Use of the USPTO’s Patent Application Alert Service
Pharma Live, , Intellectual Property Rights, 0
The U.S. Patent and Trademark Office (USPTO) recently launched the Patent Application Alert Service (PAAS), a free electronic tool aimed to...
-
Drug patents are Bad for your health: the cost of mismarketing – By Dean Baker
Pharma Live, , Intellectual Property Rights, 0
The rationale for granting patents for new drugs is to give companies incentives to research new and better drugs....
-
The new drugs war – Courtesy (The Economists)
Pharma Live, , Intellectual Property Rights, 0
OF ALL the goods and services traded in the market economy, pharmaceuticals are perhaps the most contentious. Though produced...
-
Evergreening, patent challenges, and effective market life in pharmaceuticals
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0167629612000057-mainDownload
-
Amarantus Bioscience Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Compositions Of Matter And Methods Of Use for manufacture -Courtesy (Biospace)
Pharma Live, , Intellectual Property Rights, 0
SAN FRANCISCO and GENEVA, May 5, 2015 (GLOBE NEWSWIRE) — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on...
-
The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0167629610001219-mainDownload
-
The Trans-Pacific Partnership And The Costs of Drug Patent Monopolies – Courtesy(OurFuture.org)
Pharma Live, , Intellectual Property Rights, 0
The debate over the Trans-Pacific Partnership (TPP) has taken center stage in policy circles in recent weeks. Its proponents...
-
Senator asks VA to yank patent on Gilead’s Sovaldi to crush its price – Courtesy (Fierce Pharma)
Pharma Live, , Intellectual Property Rights, 0
Gilead Sciences ($GILD) has been able to withstand scathing criticism at home over the prices of its hep C...